Cardiac Pacemakers

regarding classes of evidence from Jacobs AK, Kushner FG, Ettinger SM, et al. ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013;127(2):268-310. doi:10.1161/CIR.0b013e31827e8e5f Note: Indications described in the above table are based on guidelines in the following footnotes: † Adapted from Kusumoto FM, Schoenfeld MH, Barrett C, et al: 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay. J Am Coll Cardiol 2018, 25701. doi: 10.1016/j.jacc.2018.10.044 ‡ Adapted from Epstein AE, DiMarco JP, Ellenbogen KA, et al: 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. Circulation 117(21):e350–e408, 2008. doi: 10.1161/CIR.0b013e318276ce9b and Circulation 127(3):e283–e352, 2013 and Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022;145(18):e876- e894. doi:10.1161/CIR.0000000000001062 AF = atrial fibrillation; AV = atrioventricular; BBB = bundle branch block; CRT = cardiac resynchronization therapy; EF = ejection fraction; HV interval = interval from the His signal to the beginning of the
